2009

11-2-09
Athenix acquired by Bayer Crop Sciences for $400M

8-19-09
Athenix enters into purchase agreement to be acquired by Bayer CropScience

6-10-09
InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting

1-15-09
Peptimmune Grants Major Pharmaceutical Company Exclusive Option to License PI-2301 for Multiple Sclerosis

2008

12-16-08
Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery